Tagged with NPC

USA: Drug Innovations Are Delivering for Patients; We Need Innovation In How They’re Paid For

USA USA: Drug Innovations Are Delivering for Patients; We Need Innovation In How They’re Paid For

USA John M. O’Brien, recently appointed president and CEO of the US National Pharmaceutical Council, calls for innovation in benefit design reform to match the unparalleled speed and ingenuity with which the biopharmaceutical industry developed vaccines and therapeutics to combat the COVID-19 pandemic. The biopharmaceutical industry developed COVID-19 vaccines and…

Supporting Value-Based Purchasing in the US Through Changes in Medicaid Best Price

USA Supporting Value-Based Purchasing in the US Through Changes in Medicaid Best Price

USA Michael Ciarametaro, VP for Research at the US National Pharmaceutical Council (NPC), outlines issues surrounding the outdated Medicaid Best Price (MBP) and why there is a dire need for payment innovations to provide a way for US payers and manufacturers to share financial risk and ultimately ensure that patients can…

Accumulating Barriers to Care: Double Jeopardy for US Patients

USA Accumulating Barriers to Care: Double Jeopardy for US Patients

USA Dan Leonard, Kimberly Westrich, and Brian Sils of the National Pharmaceutical Council examine how a new HHS ruling on how US patients pay for medicines could hurt them financially, exacerbating what is already a challenging time in the midst of the COVID-19 pandemic. The pandemic has been a challenging…

Can the USA’s Fragmented Healthcare System Become More Patient-Centric?

USA Can the USA’s Fragmented Healthcare System Become More Patient-Centric?

USA US healthcare is often seen as a fragmented system of contrasts. The country has the highest healthcare expenditures as a percentage of GDP and the highest drug prices in the OECD, supporting the largest and most innovative healthcare market globally. However, it also has shockingly subpar healthcare outcomes compared to…

Dan Leonard – President & CEO, National Pharmaceutical Council (NPC), USA

USA Dan Leonard – President & CEO, National Pharmaceutical Council (NPC), USA

USA Dan Leonard is president & CEO of the National Pharmaceutical Council, which sponsors and participates in research on the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation. Leonard outlines the activities of the Council – which celebrated its 65th anniversary in 2018 – his priorities…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page